Cargando…

Deletion of PTENP1 pseudogene in human melanoma

Detalles Bibliográficos
Autores principales:	Poliseno, Laura, Haimovic, Adele, Christos, Paul J., Vega y Saenz de Miera, Eleazar C., Shapiro, Richard, Pavlick, Anna, Berman, Russell S., Darvishian, Farbod, Osman, Iman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213301/ https://www.ncbi.nlm.nih.gov/pubmed/21833010 http://dx.doi.org/10.1038/jid.2011.232

Ejemplares similares

The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
por: Huynh, Chanh, et al.
Publicado: (2011)

Correction: The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma
por: Huynh, Chanh, et al.
Publicado: (2011)

Melanoma expression of matrix metalloproteinase-23 is associated with blunted tumor immunity and poor responses to immunotherapy
por: Moogk, Duane, et al.
Publicado: (2014)

Hedgehog Pathway Blockade Inhibits Melanoma Cell Growth in Vitro and in Vivo
por: O’Reilly, Kathryn E., et al.
Publicado: (2013)

Intra- and Inter-Tumor Heterogeneity of BRAF(V600E)Mutations in Primary and Metastatic Melanoma
por: Yancovitz, Molly, et al.
Publicado: (2012)

Serum microRNAs as biomarkers for recurrence in melanoma
por: Friedman, Erica B, et al.
Publicado: (2012)

Somatic and germline analyses of a long term melanoma survivor with a recurrent brain metastasis
por: Weiss, Sarah, et al.
Publicado: (2015)

PTENP1 is a ceRNA for PTEN: it’s CRISPR clear
por: Vitiello, Marianna, et al.
Publicado: (2020)

Methylation of the PTENP1 pseudogene as potential epigenetic marker of age-related changes in human endometrium
por: Kovalenko, Tatyana F., et al.
Publicado: (2021)

Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients
por: Yu, Jessie Z, et al.
Publicado: (2008)

Decreased expression of pseudogene PTENP1 promotes malignant behaviours and is associated with the poor survival of patients with HNSCC
por: Liu, Jiannan, et al.
Publicado: (2017)

Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma
por: Chou, Margaret, et al.
Publicado: (2020)

The histone demethylase PHF8 regulates TGFβ signaling and promotes melanoma metastasis
por: Moubarak, Rana S., et al.
Publicado: (2022)

Pseudogenes in Human Cancer
por: Poliseno, Laura, et al.
Publicado: (2015)

Ensemble Modeling Approach Targeting Heterogeneous RNA-Seq data: Application to Melanoma Pseudogenes
por: Capobianco, Enrico, et al.
Publicado: (2017)

T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy
por: Krogsgaard, Michelle, et al.
Publicado: (2013)

The PTENP1 Pseudogene, Unlike the PTEN Gene, Is Methylated in Normal Endometrium, As Well As in Endometrial Hyperplasias and Carcinomas in Middle-Aged and Elderly Females
por: Kovalenko, T. F., et al.
Publicado: (2018)

An epigenetic switch controls an alternative NR2F2 isoform that unleashes a metastatic program in melanoma
por: Davalos, Veronica, et al.
Publicado: (2023)

BET and BRAF inhibitors act synergistically against BRAF‐mutant melanoma
por: Paoluzzi, Luca, et al.
Publicado: (2016)

Melanoma risk loci as determinants of melanoma recurrence and survival
por: Rendleman, Justin, et al.
Publicado: (2013)

RSK1 activation promotes invasion in nodular melanoma
por: Salhi, Amel, et al.
Publicado: (2015)

Impact of aging on host immune response and survival in melanoma: an analysis of 3 patient cohorts
por: Weiss, Sarah A., et al.
Publicado: (2016)

PTENP1-AS contributes to BRAF inhibitor resistance and is associated with adverse clinical outcome in stage III melanoma
por: Vidarsdottir, Linda, et al.
Publicado: (2021)

Engineering the immune response to "self" for effective cancer immunotherapy
por: Zhong, Shi, et al.
Publicado: (2014)

Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis
por: Lattanzi, Michael, et al.
Publicado: (2018)

Roles of Polo-like kinase 3 in suppressing tumor angiogenesis
por: Xu, Dazhong, et al.
Publicado: (2012)

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
por: Poliseno, Laura, et al.
Publicado: (2010)

Clinical relevance of Neutral Endopeptidase (NEP/CD10) in melanoma
por: Velazquez, Elsa F, et al.
Publicado: (2007)

Patterns of Nucleotide Deletion and Insertion Inferred from Bacterial Pseudogenes
por: Danneels, Bram, et al.
Publicado: (2018)

Overexpression of lncRNA PTENP1 suppresses glioma cell proliferation and metastasis in vitro
por: Hu, Su, et al.
Publicado: (2018)

Polymorphisms in lncRNA PTENP1 and the Risk of Gastric Cancer in a Chinese Population
por: Ge, Yugang, et al.
Publicado: (2017)

Pseudogenes
por: Tutar, Yusuf
Publicado: (2012)

Increased shedding of HU177 correlates with worse prognosis in primary melanoma
por: Hamilton, Heather K, et al.
Publicado: (2010)

Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression
por: Zheng, Rui, et al.
Publicado: (2018)

PTEN, PTENP1, microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics
por: Travis, Glena, et al.
Publicado: (2023)

Angiosarcoma of the Breast Masquerading as Hemangioma: Exploring Clinical and Pathological Diagnostic Challenges
por: Frey, Jordan D, et al.
Publicado: (2015)

Editorial: Role of pigmentation in melanoma
por: Brożyna, Anna A., et al.
Publicado: (2022)

Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM)
por: Ferguson, Robert, et al.
Publicado: (2019)

Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients
por: Peters, Brandilyn A., et al.
Publicado: (2019)

Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth
por: Cao, Liang-qi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m1403kkq712gombak6o3t1rfjq